Both in Pharmaceuticals
Schrodinger vs Zymeworks
Over the past year SDGR returned +42.7% and ZYME returned +70.4%; their daily moves had a correlation of 0.23.
SDGR +42.7% ZYME +70.4%Growth of $1, one year, split-adjusted
| Metric | SDGR | ZYME |
|---|---|---|
| Price | $28.52 | $30.94 |
| Market cap | $2.13B | $2.22B |
| Today | +4.93% | +2.69% |
| 1 month | −1.3% | +20.6% |
| 6 months | +119.7% | +12.1% |
| Year to date | +59.5% | +17.5% |
| 1 year | +38.8% | +63.8% |
| Revenue growth (YoY) | +7.5% | −90.6% |
| Gross margin | 55.1% | 100.0% |
| Net margin | 10.1% | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | 59.9× |
| Net cash | $413.7M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | 94.5% | 47.0% |
| Short % of float | 19.8% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).